---
audienceLevel: patient
cancerTypes:
- ovarian
citation: NCI, 2025
language: en
lastReviewed: '2025-12-30'
license: public_domain
reviewFrequency: quarterly
source: NCI
sourceType: 02_nci_core
status: active
tags:
- treatment
title: Niraparib Tosylate Monohydrate - NCI
url: https://www.cancer.gov/about-cancer/treatment/drugs/niraparibtosylatemonohydrate
version: v1
---

# Niraparib Tosylate Monohydrate - NCI

# Niraparib Tosylate Monohydrate

Placeholder slot

(nih-RA-puh-rib TOH-suh-layt MAH-noh-HY-drayt)

This page contains brief information about niraparib tosylate monohydrate
and a collection of links to more information about the use of
this drug, research results, and ongoing clinical trials.

US Brand Name(s)

Zejula

FDA Approved

Yes

[FDA label information for this drug is available at DailyMed.](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c15c7b7e-4b7f-4489-bbbc-884caeee0669&audience=consumer)

## Use in Cancer

Niraparib tosylate monohydrate
is approved to treat adults with:

- **[Ovarian epithelial](/Common/PopUps/popDefinition.aspx?id=46768&version=Patient&language=English),** **[fallopian tube](/Common/PopUps/popDefinition.aspx?id=755773&version=Patient&language=English),** or **[primary peritoneal cancer](/Common/PopUps/popDefinition.aspx?id=386215&version=Patient&language=English).** It is used:
- As [maintenance therapy](/Common/PopUps/popDefinition.aspx?id=45768&version=Patient&language=English) in patients with [advanced](/Common/PopUps/popDefinition.aspx?id=478743&version=Patient&language=English) cancer who are having a [complete](/Common/PopUps/popDefinition.aspx?id=45652&version=Patient&language=English) or [partial response](/Common/PopUps/popDefinition.aspx?id=45819&version=Patient&language=English) to [first-line](/Common/PopUps/popDefinition.aspx?id=346494&version=Patient&language=English) [platinum](/Common/PopUps/popDefinition.aspx?id=45841&version=Patient&language=English) chemotherapy.
- As maintenance therapy in patients whose cancer came back and has a [germline mutation](/Common/PopUps/popDefinition.aspx?id=46384&version=Patient&language=English) in the *[BRCA1](/Common/PopUps/popDefinition.aspx?id=46047&version=Patient&language=English)* or *[BRCA2](/Common/PopUps/popDefinition.aspx?id=46742&version=Patient&language=English)* gene. It is used in patients who are having a complete or partial response to platinum chemotherapy.

Niraparib tosylate monohydrate
is also being studied in the treatment of other types of
cancer.

## More About Niraparib Tosylate Monohydrate

[Definition from the NCI Drug Dictionary](https://www.cancer.gov/publications/dictionaries/cancer-drug/def/615263) - Detailed scientific definition and other names for this drug.

MedlinePlus Information on [Niraparib Tosylate Monohydrate](https://medlineplus.gov/druginfo/meds/a617007.html) - A lay language summary of important information about this drug that may include the following:

- warnings about this drug,
- what this drug is used for and how it is used,
- what you should tell your doctor before using this drug,
- what you should know about this drug before using it,
- other drugs that may interact with this drug, and
- possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

## Research Results and Related Resources

[Targeted Cancer Therapies](https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies)

## Clinical Trials Accepting Patients

[Find Clinical Trials for Niraparib Tosylate Monohydrate](https://www.cancer.gov/research/participate/clinical-trials/intervention/C133238) - Check for trials from NCI's list of cancer clinical trials now accepting patients.
